Expected clinical applications of circulating tumor cells in breast cancer

doi:10.5306/wjco.v2.i8.303

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5872)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series.

Item

Count

PDF

446

HTML

4843

Figures (1-9)

583

Sum=5872

Aug 10, 2011 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Oncol. Aug 10, 2011; 2(8): 303-310
Published online Aug 10, 2011. doi: 10.5306/wjco.v2.i8.303

Full Size Figure Download Figure

Figure 7 Kaplan-Meier estimates of probabilities of overall survival in patients with metastatic breast cancer who had less than 5 circulating tumor cells and those who had 5 or more circulating tumor cells (at the first follow-up visit after initiation of a new line of therapy)[29]. CTC: Circulating tumor cell.

Citation: Park Y, Kitahara T, Urita T, Yoshida Y, Kato R. Expected clinical applications of circulating tumor cells in breast cancer. World J Clin Oncol 2011; 2(8): 303-310
URL: https://www.wjgnet.com/2218-4333/full/v2/i8/303.htm
DOI: https://dx.doi.org/10.5306/wjco.v2.i8.303